logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Striking increase in incidence of prostate cancer in men aged<60 years without improvement in prognosis.

    Article - En anglais

    Increased awareness and improved diagnostic techniques have led to earlier diagnosis of prostate cancer and increased detection of subclinical cases, resulting in improved prognosis.

    We postulated that the considerable increase in incidence under age 60 is not attributable only to increased detection.

    To test this hypothesis, we studied incidence, mortality and relative survival among middle-aged patients diagnosed in south-east Netherlands and East Anglia (UK) between 1971 and 1994.

    Prostate-specific antigen (PSA) testing did not occur before 1990.

    Between 1971 and 1989, the age-standardized incidence at ages 40-59 increased from 8.8 to 12.5 per 105 in The Netherlands and from 7.0 to 11.6 per 105 in East Anglia.

    Five-year relative survival did not improve in East Anglia and even declined in south-east Netherlands from 65% [95% confidence interval (Cl) 47-83) in 1975-79 to 48% (Cl 34-62) in 1985-89.

    Mortality due to prostate cancer among men aged 45-64 years increased by 50% in south-east Netherlands and by 61% in East Anglia between 1971 and 1989, but decreased slightly in the 1990s.

    Because other factors adversely influencing the prognosis are unlikely, our results indicate an increase in the incidence of fatal prostate cancer among younger men in the era preceding PSA testing.

    Mots-clés Pascal : Tumeur maligne, Prostate, Mortalité, Pronostic, Epidémiologie, Age mûr, Pays Bas, Europe, Royaume Uni, Etude comparative, Homme, Appareil génital mâle pathologie, Appareil urinaire pathologie, Prostate pathologie

    Mots-clés Pascal anglais : Malignant tumor, Prostate, Mortality, Prognosis, Epidemiology, Middle age, Netherlands, Europe, United Kingdom, Comparative study, Human, Male genital diseases, Urinary system disease, Prostate disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0047269

    Code Inist : 002B14D02. Création : 31/05/1999.